418 related articles for article (PubMed ID: 8318174)
21. Declining incidence of AIDS dementia complex after introduction of zidovudine treatment.
Portegies P; de Gans J; Lange JM; Derix MM; Speelman H; Bakker M; Danner SA; Goudsmit J
BMJ; 1989 Sep; 299(6703):819-21. PubMed ID: 2510843
[TBL] [Abstract][Full Text] [Related]
22. [Clinical and virological correlation between the cerebrospinal fluid and blood of HIV-infected children].
Sáez-Llorens X; Castrejón de Wong MC; Castaño E; de Suman O; Báez de Ulloa C; Redondo W; Espino M
Rev Med Panama; 2001; 26():13-8. PubMed ID: 16161718
[TBL] [Abstract][Full Text] [Related]
23. Varied tropism of HIV-1 isolates derived from different regions of adult brain cortex discriminate between patients with and without AIDS dementia complex (ADC): evidence for neurotropic HIV variants.
Smit TK; Wang B; Ng T; Osborne R; Brew B; Saksena NK
Virology; 2001 Jan; 279(2):509-26. PubMed ID: 11162807
[TBL] [Abstract][Full Text] [Related]
24. AIDS dementia complex in China.
Wu YC; Zhao YB; Tang MG; Zhang-Nunes SX; McArthur JC
J Clin Neurosci; 2007 Jan; 14(1):8-11. PubMed ID: 17070055
[TBL] [Abstract][Full Text] [Related]
25. Human immunodeficiency virus-associated dementia: review of pathogenesis, prophylaxis, and treatment studies of zidovudine therapy.
Simpson DM
Clin Infect Dis; 1999 Jul; 29(1):19-34. PubMed ID: 10433561
[TBL] [Abstract][Full Text] [Related]
26. Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1-infected individuals: results from the multicenter AIDS Cohort Study.
McArthur JC; Cohen BA; Selnes OA; Kumar AJ; Cooper K; McArthur JH; Soucy G; Cornblath DR; Chmiel JS; Wang MC
Ann Neurol; 1989 Nov; 26(5):601-11. PubMed ID: 2817836
[TBL] [Abstract][Full Text] [Related]
27. [AIDS dementia complex as the 1st manifestation of the acquired immunodeficiency syndrome].
Abós J; Alom J; Graus F; Marqués G; Miró JM; Blesa R; Tolosa E
Med Clin (Barc); 1989 Dec; 93(19):731-4. PubMed ID: 2622274
[TBL] [Abstract][Full Text] [Related]
28. [AIDS dementia complex].
Abos J; Alom J; Graus F
Arch Neurobiol (Madr); 1989; 52 Suppl 1():62-7. PubMed ID: 2700297
[TBL] [Abstract][Full Text] [Related]
29. AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations.
Brew BJ; Rosenblum M; Cronin K; Price RW
Ann Neurol; 1995 Oct; 38(4):563-70. PubMed ID: 7574452
[TBL] [Abstract][Full Text] [Related]
30. Frequency and topographical distribution of CD68-positive macrophages and HIV-1 core proteins in HIV-associated brain lesions.
Neuen-Jacob E; Arendt G; Wendtland B; Jacob B; Schneeweis M; Wechsler W
Clin Neuropathol; 1993; 12(6):315-24. PubMed ID: 8287624
[TBL] [Abstract][Full Text] [Related]
31. [The effect of high-dose peroral zidovudine treatment in a 4-year-old child with HIV encephalopathy].
Zenz W; Lackner H; Maurer U; Ranner G; Puchhammer-Stöckl E
Padiatr Padol; 1992; 27(1):11-5. PubMed ID: 1560990
[TBL] [Abstract][Full Text] [Related]
32. Azidothymidine (AZT) in the treatment of symptomatic HIV-1-infected hemophiliacs.
Eichinger S; Pabinger I; Hartl H; Stain C; Mayerhofer S; Schweiger C; Kier P; Schwarzinger I; Kyrle PA; Lechner K
Thromb Haemost; 1990 Aug; 64(1):108-12. PubMed ID: 1980381
[TBL] [Abstract][Full Text] [Related]
33. Cerebrospinal fluid HIV-1 p24 antigen and culture: sensitivity and specificity for AIDS-dementia complex.
Brew BJ; Paul MO; Nakajima G; Khan A; Gallardo H; Price RW
J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):784-9. PubMed ID: 8021661
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study Group.
Chiesi A; Vella S; Dally LG; Pedersen C; Danner S; Johnson AM; Schwander S; Goebel FD; Glauser M; Antunes F
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jan; 11(1):39-44. PubMed ID: 8528731
[TBL] [Abstract][Full Text] [Related]
35. New-onset psychosis in HIV-infected patients.
Harris MJ; Jeste DV; Gleghorn A; Sewell DD
J Clin Psychiatry; 1991 Sep; 52(9):369-76. PubMed ID: 1894589
[TBL] [Abstract][Full Text] [Related]
36. Acute diffuse leukoencephalitis in HIV-1 infection.
Lüer W; Gerhards J; Poser S; Weber T; Felgenhauer K
J Neurol Neurosurg Psychiatry; 1994 Jan; 57(1):105-7. PubMed ID: 8301288
[TBL] [Abstract][Full Text] [Related]
37. Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection.
Brew BJ; Bhalla RB; Paul M; Gallardo H; McArthur JC; Schwartz MK; Price RW
Ann Neurol; 1990 Oct; 28(4):556-60. PubMed ID: 2252366
[TBL] [Abstract][Full Text] [Related]
38. [Neurological complications in 95 patients with HIV infection. A retrospective analysis of anamnestic and clinical data].
Kollegger H; Sagmeister T; Deecke L
Med Klin (Munich); 1992 Sep; 87(9):449-53. PubMed ID: 1328830
[TBL] [Abstract][Full Text] [Related]
39. [Multimodal evoked potentials in human immunodeficiency virus infection].
Somma-Mauvais H; Régis H; Gastaut JL; Gastaut JA; Farnarier G
Rev Neurol (Paris); 1990; 146(3):196-204. PubMed ID: 2184485
[TBL] [Abstract][Full Text] [Related]
40. Review of antiretroviral therapy in the prevention of HIV-related AIDS dementia complex (ADC).
Portegies P
Drugs; 1995; 49 Suppl 1():25-31; discussion 38-40. PubMed ID: 7614899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
